<DOC>
	<DOCNO>NCT01344811</DOCNO>
	<brief_summary>A randomized , open , parallel , multi-center trial evaluate weight loss efficacy Smart Care Service obese patient metabolic syndrome .</brief_summary>
	<brief_title>Effects Telemonitoring Service Obesity Care</brief_title>
	<detailed_description>1 . Objectives : To evaluate superiority U ( Ubiquitous ) -Healthcare ( hereinafter refer Smart Care ) Service combine conventional treatment health care service , comparison conventional treatment obese patient metabolic syndrome . 2 . Test control group - Test group : The subject group receive health care service use conventional treatment ( hospital visit ) Smart Care Service ( Telemonitoring ) . - Control group : The subject group receive conventional treatment ( hospital visit ) . 3 . Target Subject : Obese patient metabolic syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>1 . Age : More 20 year age 70 year age . 2 . BMI ≥ 25kg/m2 3 . Patients metabolic syndrome ( three follow 5 component metabolic syndrome ) able receive outpatient treatment . A. Abdominal obesity : Waist circumference≥90cm ( Male ) , 85cm ( Female ) B . Patients whose blood pressure ≥130/85mmHg ( systolic blood pressure 130 , diastolic blood pressure 85 ) patient take blood pressure medication . C. Fasting Blood Glucose ( FPG ) ≥ 100mg/dl . D. Patients whose triglyceride ≥150 mg/dl patient take fibrate . E. Highdensity lipoprotein cholesterol ( HDL ) &lt; 40 mg/dl ( Male ) , 50 mg/dl ( Female ) 4 . Patients able understand purpose trial read write . 5 . Patients able use Uhealthcare Smartphone trial . 6 . Patients participate voluntarily sign informed consent . 1 . Type I diabetes mellitus patient type II diabetes mellitus patient require insulin therapy . 2 . Patients currently hospitalize planning hospitalize study period . 3 . Patients diagnose myocardial infarction stroke within 1 year 4 . End Stage Renal Disease patient require renal replacement therapy , Serum creatinine level great 1.5 time upper limit normal . 5 . Females pregnant 6 . Hepatic failure ( severe hepatic dysfunction ) . Liver Function Test ( AST ALT ) great 3 time upper limit normal . 7 . Uncontrolled chronic lung disease . 8 . Patients know gallstone . 9 . Patients cognitive disorder psychiatric problem . 10 . Patients take antiobesity medication Reductil , Xenical , etc. , patient plan receive medication . 11 . Patients take Synthroid , diabetes medication psychiatric medication may affect body weight . 12 . Any clinically significant medical condition include neurologic disease , gastrointestinal disease malignant tumor , etc. , may affect test result , medical condition opinion investigator make patient unsuitable participation trial . 13 . Patients participate clinical trial ( except observational study ) within 12 week prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>telemonitoring</keyword>
	<keyword>usual care</keyword>
	<keyword>telehealth</keyword>
	<keyword>home care</keyword>
	<keyword>Health Care Quality</keyword>
	<keyword>Access</keyword>
	<keyword>Evaluation</keyword>
</DOC>